A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2011
12/01/2011	US20110294727 Compositions of nutrition supplementation for nutritional deficiencies and method of use therefore
12/01/2011	US20110294726 Antibiotic therapy to reduce the likelihood of developing post-infectious irritable bowel syndrome
12/01/2011	US20110294724 Low hemolytic antimicrobial peptide, pharmaceutical composition and use thereof
12/01/2011	US20110294723 Compounds
12/01/2011	US20110294722 Antimicrobial peptides
12/01/2011	US20110294721 Antimicrobial peptides
12/01/2011	US20110294720 Apratoxin therapeutic agents: mechanism and methods of treatment
12/01/2011	US20110294719 Dipeptoid prodrugs and the use thereof
12/01/2011	US20110294718 Dipeptoid prodrugs and the use thereof
12/01/2011	US20110294717 Therapeutic Polymeric Nanoparticle Compositions with High Glass Transition Temperature or High Molecular Weight Copolymers
12/01/2011	US20110294226 Survival motor Neurons (SMN) gene: a gene for spinal muscular atrophy
12/01/2011	US20110294219 Use of the foamy virus bet protein for inactivating apobec
12/01/2011	US20110294212 Methods of Screening Molecular Libraries and Active Molecules Identified Thereby
12/01/2011	US20110294193 Viral vectors and methods for producing and using the same
12/01/2011	US20110294162 B-7 related nucleic acids and polypeptides useful for immunomodulation
12/01/2011	US20110294146 Identification of Actinobacillus actinomycetemcomitans Antigens for Use in the Diagnosis, Treatment, and Monitoring of Periodontal Diseases
12/01/2011	US20110293750 Activated wnt-beta-catenin signaling in melanoma
12/01/2011	US20110293748 Combined preparation for treating sepsis
12/01/2011	US20110293744 Benzoxazole inhibitors of poly(adp-ribose)polymerase
12/01/2011	US20110293743 Topical Acyl Glutathione Formulations
12/01/2011	US20110293733 Self-assembling nanoparticle drug delivery system
12/01/2011	US20110293728 Photosensitizer-metal nanoparticle complex and composition containing the complex for photodynamic therapy or diagnosis
12/01/2011	US20110293727 Chimeric therapeutics, compositions, and methods for using same
12/01/2011	US20110293726 Chimeric therapeutics, compositions, and methods for using same
12/01/2011	US20110293725 Chimeric therapeutics, compositions, and methods for using same
12/01/2011	US20110293724 Enzyme Treatment of Foodstuffs for Celiac Sprue
12/01/2011	US20110293723 Synthetic nanocarrier combination vaccines
12/01/2011	US20110293722 Hydrogel sponges, methods of producing them and uses thereof
12/01/2011	US20110293715 Pharmaceutical Formulation and Process for Its Preparation
12/01/2011	US20110293714 Pharmaceutical compositions suitable for oral administration of derivatized insulin peptides
12/01/2011	US20110293707 Use of the cathelicidin ll-37 and derivatives thereof for wound healing
12/01/2011	US20110293703 Aminoalcohol lipidoids and uses thereof
12/01/2011	US20110293701 Multivalent synthetic nanocarrier vaccines
12/01/2011	US20110293695 Amphoteric liposomes
12/01/2011	US20110293692 Hydrogel implants with varying degrees of crosslinking
12/01/2011	US20110293676 Oral Cephalotaxine Dosage Forms
12/01/2011	US20110293663 Pharmaceutical botulinum toxin compositions
12/01/2011	US20110293652 Chimeric ospa genes, proteins, and methods of use thereof
12/01/2011	US20110293648 Ssx-2 peptides presented by hla class ii molecules
12/01/2011	US20110293647 Immunogenic lhrh compositions and methods relating thereto
12/01/2011	US20110293646 PAN-DR Binding Polypeptides and Uses Thereof
12/01/2011	US20110293641 A vaccinia virus protein a46 peptide and use thereof
12/01/2011	US20110293639 Ideotypically modulated pharmacoeffectors for selective cell treatment
12/01/2011	US20110293635 Composition and methods for modulating toll-like receptor activity
12/01/2011	US20110293624 Genes of an Otitis Media Isolate of NonTypeable Haemophilus Influenzae
12/01/2011	US20110293610 Antibodies that immunospecifically bind to b lymphocyte stimulator protein
12/01/2011	US20110293609 Antibody Glycosylation Variants Having Increased Antibody-Dependent Cellular Cytotoxicity
12/01/2011	US20110293602 Vegf-like factor antibodies and methods of use thereof
12/01/2011	US20110293599 Method for modulating muscle differentiation or regeneration
12/01/2011	US20110293597 Serine protease derivatives and uses in the prevention or the treatment of blood coagulation disorders
12/01/2011	US20110293596 Disease control with tick phospholipase a2
12/01/2011	US20110293595 Prophylactic and therapeutic treatment of Alzheimer's Disease, neuro-degenerative diseases, protein aggregation diseases, Parkinson's Disease and amyloid diseases, using phytic acid and phytate
12/01/2011	US20110293594 Removal of serine proteases by treatment with finely divided silicon dioxide
12/01/2011	US20110293593 Siva 2 stabilization
12/01/2011	US20110293592 Method of treating coronary arteries with perivascular delivery of therapeutic agents
12/01/2011	US20110293590 Pharmaceutical preparation
12/01/2011	US20110293588 Metabolic uncoupling therapy
12/01/2011	US20110293587 Glucagon analogues
12/01/2011	US20110293586 Glucagon analogues
12/01/2011	US20110293585 Compositions and methods for treatment of lysosomal storage disorders
12/01/2011	US20110293581 Bone-regenerating composition containing angiogenin
12/01/2011	US20110293579 Bi-specific fusion proteins
12/01/2011	US20110293578 Use of Stem Cells to Prevent Neuronal Dieback
12/01/2011	US20110293574 Hematopoietic stem cell growth factor
12/01/2011	US20110293566 Diffocin and methods of use thereof
12/01/2011	US20110293565 Novel synthetic agonists of tlr9
12/01/2011	US20110293564 2-morpholino-pyrido[3,2-d]pyrimidines
12/01/2011	US20110293563 1'substituted carba-nucleoside analogs for antiviral treatment
12/01/2011	US20110293562 Use of cardiotrophin-1 for the treatment of metabolic diseases
12/01/2011	US20110293561 Anti-kir combination treatments and methods
12/01/2011	US20110293560 Method for determining immune system activity and medicament for influencing same
12/01/2011	US20110293559 Catabolic agents
12/01/2011	US20110293558 Material properties of t cells and related methods and compositions
12/01/2011	US20110293557 Conjugates for the administration of biologically active compounds
12/01/2011	US20110293556 Treatment of insulin resistance/metabolic syndrome to alleviate the risks of dementia
12/01/2011	US20110293555 Tumor necrosis factor-alpha mutants
12/01/2011	US20110293554 Recombinant human g-csf dimer and use thereof for the treatment of neurological diseases
12/01/2011	US20110293534 Aerosol can spray incorporating a nutritional cell scaffold for use as first aid treatment for wounds/burns and for use in cell therapy/tissue repair
12/01/2011	US20110293526 Compositions and methods to modulate hair growth
12/01/2011	US20110293524 Methods and compositions for the regulation of lectin complement pathway (lcp)-associated complement activation in hyperglycemic myocardial damage
12/01/2011	US20110293521 Anti-viral compositions and methods for administration
12/01/2011	US20110293516 Compositions and methods of use of targeting peptides against placenta and adipose tissues
12/01/2011	US20110293511 Specific binding proteins and uses thereof
12/01/2011	US20110290693 Abnormal Scar Therapy
12/01/2011	DE102010022587A1 Gastric juice-resistant composition for oral ingestion of plant-based components, useful for preventing colorectal cancer, comprises glucosinolate, and a construct of glucan-melanin-chitin complex coated with plant-based component
12/01/2011	DE102010017130A1 Hybrid-Verbindung, deren Verwendung und Verfahren zu deren Herstellung Hybrid compound, use thereof and process for their preparation
12/01/2011	CA2800958A1 Macrocyclic compounds useful as inhibitors of histone deacetylases
12/01/2011	CA2800766A1 Neuregulin isoforms, neuregulin polypeptides and uses thereof
12/01/2011	CA2800744A1 Insulin-like growth factor 1 receptor binding peptides
12/01/2011	CA2800688A1 Recombinant human g-csf dimer and use thereof for the treatment of neurological diseases
12/01/2011	CA2800671A1 Modified beta-lactamases and methods and uses related thereto
12/01/2011	CA2800595A1 Compositions comprising the nc2 domain of collagen ix and methods of using same
12/01/2011	CA2800535A1 Class i mhc phosphopeptides for cancer immunotherapy and diagnosis
12/01/2011	CA2800375A1 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutaminyl-trna synthetases
12/01/2011	CA2800272A1 Removal of serine proteases by treatment with finely divided silicon dioxide
12/01/2011	CA2800253A1 Aqueous formulations for coating microneedle arrays
12/01/2011	CA2800155A1 Method for preparing an enriched igg composition from plasma
12/01/2011	CA2799572A1 Novel cyclic peptide compound, method for producing same, anti-infective agent, antibiotic-containing fraction, antibiotic, method for producing antibiotic, antibiotic-producing microorganism, and antibiotic produced by same
11/2011
11/30/2011	EP2390331A1 MicroRNA molecules
11/30/2011	EP2390330A1 MicroRNA molecules

1 ... 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 ... 3163